Revvity Inc
RVTY94.685USD
-0.375-0.39%
Handelsschluss 04/29, 16:00（ET）Kurse um 15 Minuten verzögert
11.42BMarktkapitalisierung
42.25KGV TTM
mehr Informationen über Revvity Inc Unternehmen
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Unternehmensinformationen
Unternehmens-codeRVTY
Name des UnternehmensRevvity Inc
IPO-datumJul 06, 1965
Gegründet am1947
CEODr. Prahlad R. Singh, Ph.D.
Anzahl der mitarbeiter11000
WertpapierartOrdinary Share
GeschäftsjahresendeJul 06
Addresse77 4Th Avenue
StadtWALTHAM
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl02451
Telefon17816636900
Websitehttps://www.revvity.com/
Unternehmens-codeRVTY
IPO-datumJul 06, 1965
Gegründet am1947
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
11.29K
+7.45%
Mrs. Anita Gonzales
Mrs. Anita Gonzales
Vice President, Controller
Vice President, Controller
4.52K
+19.31%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
3.02K
-28.21%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.26K
+17.81%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
42.60K
-0.26%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
23.60K
+3.43%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
23.36K
+628.47%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
22.63K
+137.66%
Umsatzaufteilung
Währung: USDUpdate-Zeit: Sun, Apr 6
Währung: USDUpdate-Zeit: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
Americas
1.22B
44.39%
United States
1.10B
39.85%
Other Foreign
1.09B
39.72%
Asia
789.33M
28.65%
Europe
742.61M
26.95%
Other
-2.19B
-79.57%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionäre
Update-Zeit: Fri, Feb 21
Update-Zeit: Fri, Feb 21
Aktionärsstatistik
Art
Aktionärsstatistik
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
Aktionärsstatistik
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
17.28%
The Vanguard Group, Inc.
11.85%
T. Rowe Price Associates, Inc.
6.21%
Janus Henderson Investors
5.29%
BlackRock Institutional Trust Company, N.A.
5.00%
Other
54.37%
Art
Aktionäre
Anteil
Investment Advisor
52.38%
Investment Advisor/Hedge Fund
34.65%
Hedge Fund
2.53%
Bank and Trust
1.60%
Pension Fund
1.55%
Research Firm
1.34%
Sovereign Wealth Fund
1.02%
Individual Investor
0.29%
Family Office
0.05%
Other
4.58%
Institutionelle Beteiligung
Update-Zeit: Mon, Jan 20
Update-Zeit: Mon, Jan 20
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q1
1212
114.89M
95.62%
-2.87M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
2023Q1
1406
108.31M
85.69%
-5.19M
2022Q4
1441
108.60M
86.00%
-7.85M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
T. Rowe Price Investment Management, Inc.
20.76M
17.28%
+2.97M
+16.69%
Dec 31, 2024
The Vanguard Group, Inc.
14.24M
11.85%
+157.96K
+1.12%
Dec 31, 2024
T. Rowe Price Associates, Inc.
7.46M
6.21%
+1.15M
+18.27%
Dec 31, 2024
Janus Henderson Investors
6.36M
5.29%
+23.65K
+0.37%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.01M
5%
-158.82K
-2.58%
Dec 31, 2024
State Street Global Advisors (US)
5.17M
4.3%
-13.79K
-0.27%
Dec 31, 2024
EdgePoint Investment Group Inc.
4.06M
3.38%
+1.37M
+51.10%
Dec 31, 2024
Mitsubishi UFJ Asset Management Co., Ltd.
3.38M
2.82%
+69.03K
+2.08%
Dec 31, 2024
Capital Research Global Investors
2.99M
2.49%
-97.75K
-3.17%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.90M
2.41%
+37.67K
+1.32%
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Update-Zeit: Sun, Apr 6
Update-Zeit: Sun, Apr 6
Name
Anteil
Otter Creek Focus Strategy ETF
2.72%
T Rowe Price Capital Appreciation Equity ETF
2.21%
Franklin Genomic Advancements ETF
1.87%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Simplify Health Care ETF
1.28%
VanEck Morningstar SMID Moat ETF
1.25%
First Trust Indxx Medical Devices ETF
1.24%
Janus Henderson US Sustainable Equity ETF
1.11%
First Trust Health Care Alphadex Fund
0.87%
ROBO Global Healthcare Technology & Innovation ETF
0.86%
Mehr Anzeigen
Otter Creek Focus Strategy ETF
Anteil2.72%
T Rowe Price Capital Appreciation Equity ETF
Anteil2.21%
Franklin Genomic Advancements ETF
Anteil1.87%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.52%
Simplify Health Care ETF
Anteil1.28%
VanEck Morningstar SMID Moat ETF
Anteil1.25%
First Trust Indxx Medical Devices ETF
Anteil1.24%
Janus Henderson US Sustainable Equity ETF
Anteil1.11%
First Trust Health Care Alphadex Fund
Anteil0.87%
ROBO Global Healthcare Technology & Innovation ETF
Anteil0.86%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
168.35M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
Apr 25, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 11, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 11, 2023
Jul 20, 2023
Jan 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 12, 2023 going ex on Apr 20, 2023
Apr 21, 2023
May 12, 2023
Apr 20, 2023
Oct 27, 2022
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 10, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Feb 10, 2023
Jan 19, 2023
Jul 22, 2022
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 11, 2022 going ex on Oct 20, 2022
Oct 21, 2022
Nov 11, 2022
Oct 20, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten